bladder cancer
Novigenix Wins €1.8M EU Grant to Work With Cancer Biomarker Consortium
The Swiss cancer liquid biopsy firm will contribute its expertise and technologies including its AI-driven LITOSeek liquid biopsy platform.
Genomictree Closing in on South Korea Approval for Bladder Cancer MDx, Aims to Begin US Trials Soon
Premium
Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.
NIH Awards Early is Good $1.6M for Bladder Cancer Monitoring Test
The firm said that it will use the money to support the clinical validation of its urine-based BCDx multiomic test to detect bladder cancer recurrence.
A. Menarini Gets European Rights to Nucleix Bladder Cancer Test
The CE-marked and FDA-cleared test analyzes disease-specific changes in 15 DNA methylation markers in urine using qPCR.
Informed Genomics, NHS to Study Use of Urine-Based Bladder Cancer Test
Studies planned for this year will be used to evaluate the accuracy of Informed Genomics' Galeas Bladder test and further studies are planned for early 2025.